Chemotactic activity in inflammatory bowel disease: Role of leukotriene B4
The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
Abstract
An important histologic feature of inflammatory bowel disease (IBD) is infiltration of the colonic mucosa with neutrophils. To investigate the nature of the chemotactic agents responsible for this infiltration, colonic mucosa from three normals and nine patients with inflammatory bowel disease (seven ulcerative colitis, two Crohn's colitis) was assayed for chemotactic activity for human neutrophils in vitro in a Boyden chamber. There was more (greater than 10-fold more) chemotactic activity in homogenates of inflammatory bowel disease mucosa than in homogenates of normal colonic mucosa. Analysis of the chemotactic activity in the inflammatory bowel disease mucosa revealed that most was lipid extractable. Moreover, when the lipid extract was fractionated by reverse-phase high-pressure liquid chromatography, the only fraction with significant chemotactic activity was the fraction that coeluted with leukotriene B4. The chemotactic response to IBD mucosa was blocked by anti-LTB4 antisera. The amount of chemotactic activity in lipid extracts of different inflammatory bowel disease specimens correlated well with the concentration of leukotriene B4 measured by UV absorbance (250 ng/g of mucosa). These data suggest that leukotriene B4 is an important stimulus to neutrophil chemotaxis in inflammatory bowel disease and, thus, may play a major role in the amplification of the inflammatory response in this condition.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“that mediate immune cell recruitment (44,45)”
From Contributions of microbiome and mechanical deformation to intestinal bacterial overgrowth and inflammation in a human gut-on-a-chip (2016) · cites this paper as [44]
Citations
Cites
Ford-Hutchinson, A. W., Bray, M. A., Doig, M. V., Shipley, M. E., & Smith, M. J. H. (1980) · Nature · doi:10.1038/286264a0 · Cited by 2,060
Quantitative assay for acute intestinal inflammation based on myeloperoxidase activity
Krawisz, J. E., Sharon, P., & Stenson, W. F. (1984) · Gastroenterology · doi:10.1016/0016-5085(84)90202-6 · Cited by 1,758
Dahlén, S. E., Björk, J., Hedqvist, P., Arfors, K. E., Hammarström, S., Lindgren, J. A., & Samuelsson, B. (1981) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.78.6.3887 · Cited by 1,019
N-formylmethionyl peptides as chemoattractants for leucocytes.
Schiffmann, E., Corcoran, B. A., & Wahl, S. M. (1975) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.72.3.1059 · Cited by 881
Enhanced synthesis of leukotriene B4 by colonic mucosa in inflammatory bowel disease
Sharon, P., & Stenson, W. F. (1984) · Gastroenterology · doi:10.1016/s0016-5085(84)80015-3 · Cited by 738
Self-citationBorgeat, P., & Samuelsson, B. (1979) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)30120-5 · Cited by 648
The importance of phospholipase-A2 in prostaglandin biosynthesis
Flower, R. J., & Blackwell, G. J. (1976) · Biochemical Pharmacology · doi:10.1016/0006-2952(76)90216-1 · Cited by 642
Sharon, P., Ligumsky, M., Rachmilewitz, D., & Zor, U. (1978) · PubMed · Cited by 451
Research works printed but not linked: 2
- Lauritsen K, Laursen LS, Bukhave K, Rask-Madsen J: Effects of systemic prednisolone on arachidonic acid metabolites determined by equilibriumin vivo dialysis of rectum in severe relapsing ulcerative colitis. Gastroenterology 88:1466, 1985 (abstract)
- Peskar BM, Dreyling KW, Hoppe U, Schaarschmidt K, Goebell H, Peskar BA: Formation of sulfidopeptide-leukotrienes (SP-LT) in normal human colonic tissue, colonic carcinoma, and Crohn's disease. Gastroenterology 88:1537, 1985 (abstract)
Cited by
Podolsky, D. K. (1991) · New England Journal of Medicine · doi:10.1056/nejm199109263251306 · Cited by 1,231
Kim, H. J., Li, H., Collins, J. J., & Ingber, D. E. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1522193112 · Cited by 922
Eicosanoids and the gastrointestinal tract
Eberhart, C. E., & Dubois, R. N. (1995) · Gastroenterology · doi:10.1016/0016-5085(95)90296-1 · Cited by 414
Dietary Supplementation with Fish Oil in Ulcerative Colitis
Stenson, W. F., Cort, D., Rodgers, J., Burakoff, R., DeSchryver-Kecskemeti, K., Gramlich, T. L., & Beeken, W. (1992) · Annals of Internal Medicine · doi:10.7326/0003-4819-116-8-609 · Cited by 392
The Dual Role of Neutrophils in Inflammatory Bowel Diseases
Wéra, O., Lancellotti, P., & Oury, C. (2016) · Journal of Clinical Medicine · doi:10.3390/jcm5120118 · Cited by 316
“Nevertheless, while LTB4 has been demonstrated to be an important stimulus for neutrophil chemotaxis in IBD, with the chemotactic response being higher in UC than in CD, other studies have shown a decreased neutrophil sensibility to LTB4 in both UC and CD [137,138].”
ResultHawthorne, A. B., Daneshmend, T. K., Hawkey, C. J., Belluzzi, A., Everitt, S. J., Holmes, G. K., Malkinson, C., Shaheen, M. Z., & Willars, J. E. (1992) · Gut · doi:10.1136/gut.33.7.922 · Cited by 300
Therapeutic options for 5-lipoxygenase inhibitors
Werz, O., & Steinhilber, D. (2006) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2006.05.009 · Cited by 260
IL-8 as an important chemoattractant for neutrophils in ulcerative colitis and Crohn's disease
MITSUYAMA, K., TOYONAGA, A., SASAKI, E., WATANABE, K., TATEISHI, H., NISHIYAMA, T., SAIKI, T., IKEDA, H., TSURUTA, O., & TANIKAWA, K. (2008) · Clinical and Experimental Immunology · doi:10.1111/j.1365-2249.1994.tb06047.x · Cited by 236
CAPRILLI, R., ANDREOLI, A., CAPURSO, L., CORRAO, G., ALBASIO, G. D., GIOIENI, A., ASSUERO LANFRANCHI, G., PALADINI, I., PALLONE, F., PONTI, V., et al. (1994) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.1994.tb00158.x · Cited by 213
NUTRITION AND INFLAMMATORY BOWEL DISEASE
Han, P. D., Burke, A., Baldassano, R. N., Rombeau, J. L., & Lichtenstein, G. R. (1999) · Gastroenterology Clinics of North America · doi:10.1016/s0889-8553(05)70063-7 · Cited by 154
Effects of chemical sympathectomy and sensory nerve ablation on experimental colitis in the rat
McCafferty, D. M., Wallace, J. L., & Sharkey, K. A. (1997) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.1997.272.2.g272 · Cited by 152
Designing therapeutically effective 5-lipoxygenase inhibitors
McMillan, R. M., & Walker, E. R. H. (1992) · Trends in Pharmacological Sciences · doi:10.1016/0165-6147(92)90100-k · Cited by 147
The mode of action of the aminosalicylates in inflammatory bowel disease
GREENFIELD, S. M., PUNCHARD, N. A., TEARE, J. P., & THOMPSON, R. P. H. (1993) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.1993.tb00110.x · Cited by 144
Weisz, G., Lavy, A., Adir, Y., Melamed, Y., Rubin, D., Eidelman, S., & Pollack, S. (1997) · Journal of Clinical Immunology · doi:10.1023/a:1027378532003 · Cited by 143
Inflammatory Mediators in Gastrointestinal Defense and Injury
Wallace, J. L., & Chin, B. C. (1997) · Experimental Biology and Medicine · doi:10.3181/00379727-214-44087 · Cited by 135
Mahida, Y. R., Lamming, C. E., Gallagher, A., Hawthorne, A. B., & Hawkey, C. J. (1991) · Gut · doi:10.1136/gut.32.1.50 · Cited by 133
Beneficial effects of local or systemic lidocaine in experimental colitis
McCafferty, D. M., Sharkey, K. A., & Wallace, J. L. (1994) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.1994.266.4.g560 · Cited by 132
Camuesco, D., Comalada, M., Concha, Á., Nieto, A., Sierra, S., Xaus, J., Zarzuelo, A., & Gálvez, J. (2006) · Clinical Nutrition · doi:10.1016/j.clnu.2005.12.009 · Cited by 124
Silliman, C. C., Elzi, D. J., Ambruso, D. R., Musters, R. J. P., Hamiel, C. R., Harbeck, R. J., Paterson, A. J., Bjornsen, A. J., Wyman, T. H., Kelher, M. R., et al. (2003) · Journal of Leukocyte Biology · doi:10.1189/jlb.0402179 · Cited by 113
Role of reactive oxygen species in intestinal diseases
van der Vliet, A., & Bast, A. (1992) · Free Radical Biology and Medicine · doi:10.1016/0891-5849(92)90103-n · Cited by 110
Preventative Effects of Lactulose in the Trinitrobenzenesulphonic Acid Model of Rat Colitis
Camuesco, D., Peran, L., Comalada, M., Nieto, A., Di Stasi, L. C., Rodriguez-Cabezas, E. M., Concha, A., Zarzuelo, A., & Galvez, J. (2005) · Inflammatory Bowel Diseases · doi:10.1097/01.mib.0000160808.30988.d9 · Cited by 109
Rodríguez‐Cabezas, M. E., Gálvez, J., Camuesco, D., Lorente, M., Concha, Á., Martínez‐Augustin, O., Redondo, L., & Zarzuelo, A. (2003) · Clinical Nutrition · doi:10.1016/s0261-5614(03)00045-1 · Cited by 107
“Different mediators participate in the recruitment and activation of these cells, including LTB4 (37), and the inhibition in the synthesis and/or release of this mediator can result in a lower leukocyte infiltrate.”
Effects ofBoswellia serratain mouse models of chemically induced colitis
Kiela, P. R., Midura, A. J., Kuscuoglu, N., Jolad, S. D., Sólyom, A. M., Besselsen, D. G., Timmermann, B. N., & Ghishan, F. K. (2004) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00433.2004 · Cited by 107
The role of mycobacteria in Crohn's disease
Thompson, D. E. (1994) · Journal of Medical Microbiology · doi:10.1099/00222615-41-2-74 · Cited by 109
Inflammatory Mediators in Gastrointestinal Defense and Injury
Wallace, J. L., & Ma, L. (2001) · Experimental Biology and Medicine · doi:10.1177/153537020122601107 · Cited by 97
Role of Eicosanoids as Mediators of Inflammation in Inflammatory Bowel Disease
Stenson, W. F. (1990) · Scandinavian Journal of Gastroenterology · doi:10.3109/00365529009091903 · Cited by 93
Colonic expression of leukotriene-pathway enzymes in inflammatory bowel diseases
Jupp, J., Hillier, K., Elliott, D. H., Fine, D. R., Bateman, A. C., Johnson, P. A., Cazaly, A. M., Penrose, J. F., & Sampson, A. P. (2007) · Inflammatory Bowel Diseases · doi:10.1002/ibd.20094 · Cited by 89
Proinflammatory effects of local abdominal irradiation on rat gastrointestinal tract
Buell, M. G., & Harding, R. (1989) · Digestive Diseases and Sciences · doi:10.1007/bf01536261 · Cited by 87
“It is well known that leukotrienes, particularly leukotriene B4, are potent neutrophil chemoattractants (33-35) and potential mediators of the inflammatory response.”
BackgroundImmunophysiology of Intestinal Electrolyte Transport
Powell, D. W. (1991) · Wiley eBooks · doi:10.1002/cphy.cp060425 · Cited by 82
Anton, P. A., Targan, S. R., & Shanahan, F. (1989) · Gastroenterology · doi:10.1016/0016-5085(89)91410-8 · Cited by 80
Masoodi, M., Pearl, D. S., Eiden, M., Shute, J. K., Brown, J. F., Calder, P. C., & Trebble, T. M. (2013) · PLoS ONE · doi:10.1371/journal.pone.0076532 · Cited by 87
“LTB4 is reported to be elevated in inflamed mucosa in UC; however, critical review of published methods reveals that levels were measured in in vivo rectal dialysates or mucosal explants, which would have led to neutrophil activation inadvertently or by design [40–48].”
ResultA Novel Hepatointestinal Leukotriene B4 Receptor
Wang, S., Gustafson, E. L., Pang, L., Qiao, X., Behan, J., Maguire, M., BAYNE, M. L., & Laz, T. M. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m004512200 · Cited by 75
Leukocyte adherence in rat mesenteric venules: Effects of adenosine and methotrexate
Asako, H., Wolf, R. E., & Granger, D. N. (1993) · Gastroenterology · doi:10.1016/0016-5085(93)90832-w · Cited by 76
Serum Fatty Acids Are Correlated with Inflammatory Cytokines in Ulcerative Colitis
Wiese, D. M., Horst, S., Brown, C. T., Allaman, M. M., Hodges, M. E., Slaughter, J. C., Druce, J. P., Beaulieu, D. B., Schwartz, D. A., Wilson, K. T., et al. (2016) · PLoS ONE · doi:10.1371/journal.pone.0156387 · Cited by 77
Sasaki, Hirata, Maemura, Hamamoto, Murano, Toshina, & Katsu (2000) · Scandinavian Journal of Immunology · doi:10.1046/j.1365-3083.2000.00623.x · Cited by 75
Immunology of Inflammatory Bowel Disease
Shanahan, F., & Targan, S. R. (1989) · Springer eBooks · doi:10.1007/978-1-4613-0781-5_17 · Cited by 67
Polymeros, D., Bogdanos, D. P., Day, R. M., Arioli, D., Vergani, D., & Forbes, A. (2006) · Gastroenterology · doi:10.1053/j.gastro.2006.04.021 · Cited by 66
Effects of zileuton, a new 5-lipoxygenase inhibitor, in experimentally induced colitis in rats
Zingarelli, B., Squadrito, F., Graziani, P., Camerini, R., & Caputi, A. P. (1993) · Inflammation Research · doi:10.1007/bf01998968 · Cited by 65
Clemett, D., & Markham, A. (2000) · Drugs · doi:10.2165/00003495-200059040-00016 · Cited by 64
“These mediators and other eicosanoids such as PGD2 and PGE2 are thought to be important inflammatory agents in IBD.”
BackgroundInfluential5-Lipoxygenase inhibitors for the treatment of inflammatory bowel disease.
Rask-Madsen, J., Bukhave, K., Laursen, L., & Lauritsen, K. (1992) · PubMed · Cited by 62
Eicosanoids and inflammatory bowel disease: Regulation and prospects for therapy
Fretland, D. J., Djurić, S. W., & Gaginella, T. S. (1990) · Prostaglandins Leukotrienes and Essential Fatty Acids · doi:10.1016/0952-3278(90)90135-8 · Cited by 59
Salicylates for ulcerative colitis—their mode of action
Travis, S. P. L., & Jewell, D. P. (1994) · Pharmacology & Therapeutics · doi:10.1016/0163-7258(94)90042-6 · Cited by 63
Izutani, R., Loh, E. Y., Reinecker, H., Ohno, Y., Fusunyan, R. D., Lichtenstein, G. R., Rombeau, J. L., & MacDermott, R. P. (1995) · Inflammatory Bowel Diseases · doi:10.1002/ibd.3780010106 · Cited by 57
5-lipoxygenase: enzyme expression and regulation of activity
Steinhilber, D. (1994) · Pharmaceutica Acta Helvetiae · doi:10.1016/0031-6865(94)90024-8 · Cited by 55
Grimminger, F., FÜHRER, D., Papavassilis, C., Schlotzer, E., Mayer, K., Heuer, K.-U., KISS, L., WALMRATH, D., Piberhofer, S., Lübbecke, F., et al. (1993) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.1993.tb01290.x · Cited by 52
Carrigan, S. O., Weppler, A., Issekutz, A. C., & Stadnyk, A. W. (2005) · Immunology · doi:10.1111/j.1365-2567.2005.02131.x · Cited by 55
Dias, V. C., Wallace, J. L., & Parsons, H. (1992) · Gut · doi:10.1136/gut.33.5.622 · Cited by 51
Haeggström, J. Z., Kull, F., Rudberg, P., Tholander, F., & Thunnissen, M. M. G. M. (2002) · Prostaglandins & Other Lipid Mediators · doi:10.1016/s0090-6980(02)00051-5 · Cited by 57
Protective Role of the Epithelium of the Small Intestine and Colon
Gibson, P. R., Anderson, R. P., Mariadason, J. M., & Wilson, A. J. (1996) · Inflammatory Bowel Diseases · doi:10.1002/ibd.3780020412 · Cited by 48
Whittle, B. J. R., Varga, C., Berkó, A. M., Horvath, K., Pósa, A., Riley, J. P., Lundeen, K. A., Fourie, A., & Dunford, P. J. (2007) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707645 · Cited by 47
“…LTB4 can be found in the inflamed colonic tissue from both experimental models (Boughton-Smith et al., 1988a, b; Rachmilewitz et al., 1989; Wallace and Keenan, 1990) and patients with colitis (Boughton-Smith et al., 1983; Sharon and Stenson, 1984; Lobos et al., 1987; Hawthorne et al., 1992).”
BackgroundLeukotriene B4 potentiates colonic ulceration in the rat
Wallace, J. L., & Keenan, C. M. (1990) · Digestive Diseases and Sciences · doi:10.1007/bf01540411 · Cited by 47
Inflammatory intermediaries in inflammatory bowel disease
Lauritsen, K., Laursen, L., Bukhave, K., & Rask-Madsen, J. (1989) · International Journal of Colorectal Disease · doi:10.1007/bf01646865 · Cited by 46
Izutani, R., Loh, E. Y., Reinecker, H., Ohno, Y., Fusunyan, R. D., Lichtenstein, G. R., Rombeau, J. L., & MacDermott, R. P. (1995) · Inflammatory Bowel Diseases · doi:10.1097/00054725-199503000-00005 · Cited by 46
Role of cytokines and platelet-activating factor in inflammatory bowel disease
Nassif, A. S., Longo, W. E., Mazuski, J. E., Vernava, A. M., & Kaminski, D. L. (1996) · Diseases of the Colon & Rectum · doi:10.1007/bf02068079 · Cited by 45
Leukotriene B4 Mediates Inflammation via TRPV1 in Duct Obstruction-Induced Pancreatitis in Rats
Vigna, S. R., Shahid, R. A., Nathan, J. D., McVey, D. C., & Liddle, R. A. (2011) · Pancreas · doi:10.1097/mpa.0b013e318214c8df · Cited by 45
“Leukotriene B4 is elevated in inflamed intestinal tissue in animals and humans.(23,24) Inhibition of the rate-limiting enzyme in LTB4 biosynthesis, 5-LO, reduces tissue levels of LTB4 and inhibits enteritis in animals 27,29,30,37 and humans.”
BackgroundCOLE, A. T., Pilkington, B. J., McLaughlan, J. M., Smith, C. R., Balsitis, M., & Hawkey, C. J. (1996) · Gut · doi:10.1136/gut.39.2.248 · Cited by 44
Almallah, Z., Eltahir, Heys, Richardson, & Eremin, I. (2000) · European Journal of Clinical Investigation · doi:10.1046/j.1365-2362.2000.00581.x · Cited by 50
Carrigan, S. O., Pink, D., & Stadnyk, A. W. (2007) · Journal of Leukocyte Biology · doi:10.1189/jlb.0806528 · Cited by 44
“Yet a number of lines of evidence have suggested that other neutrophil chemoattractants might be present in the inflamed intestinal lumen and therefore likely contribute to recruiting neutrophils into and across the intestinal epithelium [6, 7].”
BackgroundAlzoghaibi, M. A., Walsh, S. W., Willey, A., Yager, D. R., Fowler, A. A., & Graham, M. F. (2004) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00189.2003 · Cited by 44
Stojadinovic, A., Kiang, J. G., Goldhill, J., Matin, D., Smallridge, R. C., Galloway, R. J., & Shea‐Donohue, T. (1997) · Critical Care Medicine · doi:10.1097/00003246-199702000-00020 · Cited by 39
5-Lipoxygenase inhibitors for the treatment of inflammatory bowel disease
Rask-Madsen, J., Bukhave, K., Laursen, L., & Lauritsen, K. (1992) · Inflammation Research · doi:10.1007/bf01991022 · Cited by 45
Dias, V. C., & Parsons, H. (1995) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)39889-8 · Cited by 38
Lampinen, M., Sangfelt, P., Taha, Y., & Carlson, M. (2008) · International Journal of Colorectal Disease · doi:10.1007/s00384-008-0509-x · Cited by 37
The effect of antioxidant therapy on colonic inflammation in the rat
Yavuz, Y., Yüksel, M., Yeğen, B. Ç., & Ali̇can, İ. (1999) · Research in Experimental Medicine · doi:10.1007/s004330050137 · Cited by 36
Bile salts determine leukotriene B4 synthesis in a human intestinal cell line (CaCo-2)
Dias, V. C., Shaffer, E. A., Wallace, J. L., & Parsons, H. (1994) · Digestive Diseases and Sciences · doi:10.1007/bf02087427 · Cited by 34
Mahami, S., Salehi, M., Mehrabi, M., Vahedi, H., Hassani, M. S., Bitaraf, F. S., & Omri, A. (2023) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2023.125332 · Cited by 34
Hawthorne, A. B., Boughton-Smith, N. K., Whittle, B. J. R., & Hawkey, C. J. (1992) · Gut · doi:10.1136/gut.33.4.513 · Cited by 32
Bahrami, G., Malekshahi, H., Miraghaee, S., Madani, H., Babaei, A., Mohammadi, B., & Hatami, R. (2020) · Clinical Nutrition Research · doi:10.7762/cnr.2020.9.3.223 · Cited by 30
“By stimulating or degrading the mucosa by acetic acid, the production of a series of leukotrienes, prostaglandins and thromboxanes increases in wounded colitis [26,27].”
BackgroundSato, K., KANAZAWA, A., Ota, N., Nakamura, T., & Fujimoto, K. (1998) · Journal of Nutritional Science and Vitaminology · doi:10.3177/jnsv.44.769 · Cited by 28
Essential fatty acids are antagonists of the leukotriene B4 receptor
Yagaloff, K. A., Franco, L., Simko, B. A., & Burghardt, B. (1995) · Prostaglandins Leukotrienes and Essential Fatty Acids · doi:10.1016/0952-3278(95)90029-2 · Cited by 28
10 Nutrition and ulcerative colitis
Burke, A., Lichtenstein, G. R., & Rombeau, J. L. (1997) · Baillière s Clinical Gastroenterology · doi:10.1016/s0950-3528(97)90059-2 · Cited by 28
Costea, I., Mack, D. R., Israel, D. M., Morgan, K. W., Krupoves, A., Seidman, E. G., Deslandres, C., Lambrette, P., Grimard, G., Levy, E. H., et al. (2010) · PLoS ONE · doi:10.1371/journal.pone.0015672 · Cited by 28
“The greatly enhanced mucosal synthesis of LTB4 in IBD [16,17] or in rectal diasylate [33,34] of IBD patients has been related, in part, to the increased infiltration of neutrophils into the intestinal tissues [35].”
BackgroundArtru, F., McPhail, M. J. W., Triantafyllou, E., & Trovato, F. M. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.867261 · Cited by 32
Prescott, S. M., & Stenson, W. F. (2005) · Nature Medicine · doi:10.1038/nm0605-596 · Cited by 26
Oketani, K., Nagakura, N., Harada, K., & Inoue, T. (2001) · European Journal of Pharmacology · doi:10.1016/s0014-2999(01)01022-6 · Cited by 26
Evaluation of the Role of Neutrophils in the Pathogenesis of Acetic Acid-Induced Colitis in Mice
Higa, A., Eto, T., & Nawa, Y. (1997) · Scandinavian Journal of Gastroenterology · doi:10.3109/00365529709025100 · Cited by 26
Clinical relevance of oxygen radicals in inflammatory bowel disease — Facts and fashion
Allgayer, H. (1991) · Journal of Molecular Medicine · doi:10.1007/bf01645146 · Cited by 31
“accumulation of neutrophils into the mucosa able to produce a variety of inflammatory mediators including leukotrienes are prominent features [15, 19].”
BackgroundA multi-city study of drug misuse in Europe.
Hartnoll, R., Avico, U., Fr, I., Lange, K. J., Lenke, L., O'Hare, A., & de Roij-Motshagen, A. (1989) · PubMed · Cited by 32
New lactic acid bacteria for skin health via oral intake of heat-killed or live cells
Kimoto‐Nira, H. (2018) · Animal Science Journal · doi:10.1111/asj.13017 · Cited by 25
Allais, L., Smet, R. D., Verschuere, S., Talavera, K., Cuvelier, C. A., & Maes, T. (2016) · Pathobiology · doi:10.1159/000446568 · Cited by 27
The 5-lipoxygenase pathway in cultured human intestinal epithelial cells
Cortese, J. F., Spannhake, E. W., Eisinger, W., Potter, J. J., & Yang, V. W. (1995) · Prostaglandins · doi:10.1016/0090-6980(95)00003-s · Cited by 26
5-Lipoxygenase inhibitors for the treatment of inflammatory bowel disease
Rask-Madsen, J., Bukhave, K., Laursen, L., & Lauritsen, K. (1992) · Inflammation Research · doi:10.1007/bf01996094 · Cited by 74
IL-2 production by intestinal lamina propria cells in normal inflamed and cancer-bearing colons
Pullman, W. E., & Doe, W. F. (1992) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.1992.tb03052.x · Cited by 24
Neutrophil recruitment to the gastrointestinal tract
Kozol, R. A. (1992) · Journal of Surgical Research · doi:10.1016/0022-4804(92)90053-3 · Cited by 23
Comparison of leukocyte excretion and blood loss in inflammatory disease of the bowel.
Teahon, K., & Bjarnason, I. (1993) · Gut · doi:10.1136/gut.34.11.1535 · Cited by 22
Giménez‐Bastida, J. A., González‐Sarrías, A., Espín, J. C., & Schneider, C. G. (2020) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.202000129 · Cited by 23
“LTB4 is a potent chemoattractant agent that recruits neutrophils to the inflamed intestine, where it can promote epithelial injury through the production of reactive oxygen species [11].”
BackgroundBing, S. R., Kinouchi, T., Kataoka, K., Kuwahara, T., & Ohnishi, Y. (1998) · Microbiology and Immunology · doi:10.1111/j.1348-0421.1998.tb02348.x · Cited by 23
The Role of Leukotriene B4 in Clostridium difficile Toxin A--Induced Ileitis in Rats
McVey, D. C., & Vigna, S. R. (2005) · Gastroenterology · doi:10.1053/j.gastro.2005.03.017 · Cited by 22
EICOSANOIDS AND INFLAMMATORY BOWEL DISEASE
Yang, V. W. (1996) · Gastroenterology Clinics of North America · doi:10.1016/s0889-8553(05)70249-1 · Cited by 24
Inflammatory bowel disease part I: Nature and pathogenesis
Kirsner, J. B. (1991) · Disease-a-Month · doi:10.1016/0011-5029(91)90024-6 · Cited by 29
Current concepts of the pathogenesis of inflammatory bowel disease
Shanahan, F. (1994) · Irish Journal of Medical Science (1971 -) · doi:10.1007/bf02943022 · Cited by 21
Nishikawa, M., Hikasa, Y., Hori, K., Tanida, N., & Shimoyama, T. (1995) · Journal of Gastroenterology · doi:10.1007/bf01211372 · Cited by 20
Dietary Fat, Immunity, and Inflammatory Disease
Boissonneault, G. A. (2007) · Food science and technology · doi:10.1201/9781420006902.ch41 · Cited by 21
Hawkey, C. J., Mahida, Y. R., & Hawthorne, A. B. (1992) · Inflammation Research · doi:10.1007/bf01991019 · Cited by 20
5-lipoxygenase: a rational target for therapy of inflammatory bowel disease?
Wallace, J. L. (1990) · Trends in Pharmacological Sciences · doi:10.1016/0165-6147(90)90313-w · Cited by 20
Kojima, R., Hamamoto, S., 森脇, 正., Iwadate, K., & Ohwaki, T. (2001) · Folia Pharmacologica Japonica · doi:10.1254/fpj.118.123 · Cited by 19
Ko, J. K.-S., & Cho, C. (2005) · Toxicological Sciences · doi:10.1093/toxsci/kfi238 · Cited by 24
“As a result, most of the chemotactic activities were blocked by anti-LTB4 antibody as demonstrated in some in vitro studies, suggesting that LTB4 could be one of the major chemotactic factors in UC (Lobos et al., 1987).”
BackgroundSawyerr, A. M., Wakefield, A. J., Hudson, M., Dhillon, A. P., & Pounder, R. E. (1991) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.1991.tb00001.x · Cited by 19
The Role of Arachidonic Acid Regulatory Enzymes in Colorectal Disease
Abir, F., Alva, S., Kaminski, D. L., & Longo, W. E. (2005) · Diseases of the Colon & Rectum · doi:10.1007/s10350-005-0015-y · Cited by 16
Pharmacology and Pathophysiology of 5-Lipoxygenase Products
Wasserman, M. A., Smith, E. F., Underwood, D. C., & Barnette, M. A. (1991) · Elsevier eBooks · doi:10.1016/b978-0-12-197800-6.50005-6 · Cited by 15
Metadata
- Authors
- Lobos, E. A., Sharon, P., & Stenson, W. F.
- Affiliations
- Washington University in St. Louis (US)
- Venue
- Digestive Diseases and Sciences
- Published
- 1987-12
- Volume
- 32
- Issue
- 12
- Pages
- 1380-1388
- ISSN
- 0163-2116 (ISSN-L)
- 1573-2568
- OpenAlex
- W2322570099
- Cited by
- 143
- References
- 32
- Citations by year
- 2024: 1 · 2023: 1 · 2022: 2 · 2021: 1 · 2020: 2 · 2019: 3 · 2018: 1 · 2016: 3 · 2015: 1 · 2013: 1
- FWCI
- 3.22
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Digestive Diseases and Sciences (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (5r01am033165-02)
- Topics
- Health Sciences › Medicine › Gastroenterology › Inflammatory Bowel Disease
- Health Sciences › Medicine › Pharmacology (medical) › Inflammatory mediators and NSAID effects
- Health Sciences › Medicine › Ophthalmology › Ocular Diseases and Behçet’s Syndrome
- Keywords
- inflammatory bowel disease, neutrophil chemotaxis, leukotriene B4, colonic mucosa, ulcerative colitis, Crohn's disease, mucosal inflammation
- MeSH terms
- Adult, Chemotactic Factors, Chemotaxis, Leukocyte, Chromatography, High Pressure Liquid, Colitis, Ulcerative, Crohn Disease, Female, Humans, Intestinal Mucosa, Leukotriene B4, Male, Middle Aged, Neutrophils
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.